Parental Decision-Making for Children With Relapsed Neuroblastoma (NCT02282735)
๐ฉบ Plain-English Summary (8th-Grade Level)
Parental decision-making for children with advanced cancer is complex. Many parents have overly optimistic beliefs about prognosis and as a result choose aggressive measures even at the end of life, which are associated with greater suffering. Yet most parents wish to limit suffering, and in retrospect, many regret choices for cancer treatment for advanced cancer. These findings suggest that parents do not always have the information they need to make decisions that reflect their preferences. The proposed study will evaluate parental decision-making in advanced cancer, addressing gaps in the literature in 3 important respects. 1) Previous work on decision-making for children with advanced cancer has typically looked at decisions at one point in time, often asking parents to reflect on decisions after the child's death, even though parents' understanding of prognosis and decisions about care evolve over time. We will evaluate parental decision-making for advanced cancer over time. 2) Existing work focuses on aggressive end-of-life care as the worst possible outcome. However, some parents wish to pursue aggressive measures even when they recognize that the child has little chance for cure. We will evaluate the extent to which parental decision-making is informed and consonant with preferences, regardless of whether decisions lead to aggressive or palliative care. 3) Previous studies have focused on groups of different childhood cancers, making it difficult to ascertain whether differences in decision-making reflect differences in diseases, options for care, or parent preferences. We will focus on a single disease, relapsed neuroblastoma, as a model for parental decision-making.
Who can join: Review the eligibility criteria below.
Location: Children's Hospital of Los Angeles โ Los Angeles, California
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (9 Sites)
- Children's Hospital of Los Angeles โ Los Angeles, California
- Stanford/Packard's Children's Hospital โ Palo Alto, California
- The University of Chicago Medical Center โ Chicago, Illinois
- Dana-Farber Cancer Institute โ Boston, Massachusetts
- Columbia University Medical Center โ New York, New York
- The Children's Hospital of Philadelphia โ Philadelphia, Pennsylvania
- St. Jude Children's Research Hospital โ Memphis, Tennessee
- Cook's Children's Healthcare System โ Fort Worth, Texas
- Seattle Children's Hospital โ Seattle, Washington
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Relapsed Neuroblastoma
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) โ Houston, Texas
- NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma โ Houston, Texas
- Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma โ Boston, Massachusetts
- NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab โ Columbus, Ohio
Explore by condition: All Relapsed Neuroblastoma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.